11.00
Adapthealth Corp stock is traded at $11.00, with a volume of 1.85M.
It is down -2.77% in the last 24 hours and up +8.06% over the past month.
AdaptHealth Corp is engaged in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. It focuses on providing; sleep therapy equipment, supplies, and related services (including CPAP and bi-PAP services) to individuals suffering from obstructive sleep apnea (OSA), medical devices and supplies to patients for the treatment of diabetes (including continuous glucose monitors (CGM and insulin pumps), home medical equipment to patients discharged from acute care and other facilities, oxygen and related chronic therapy services in the home, and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy and nutritional supply needs.
See More
Previous Close:
$11.38
Open:
$11.38
24h Volume:
1.85M
Relative Volume:
1.36
Market Cap:
$1.55B
Revenue:
$3.26B
Net Income/Loss:
$-214.34M
P/E Ratio:
-6.6667
EPS:
-1.65
Net Cash Flow:
$229.32M
1W Performance:
+29.42%
1M Performance:
+8.06%
6M Performance:
+1.70%
1Y Performance:
+5.18%
Adapthealth Corp Stock (AHCO) Company Profile
Name
Adapthealth Corp
Sector
Industry
Phone
610-630-6357
Address
220 WEST GERMANTOWN PIKE, PLYMOUTH MEETING, PA
Compare AHCO with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
AHCO
Adapthealth Corp
|
11.00 | 1.55B | 3.26B | -214.34M | 229.32M | -1.65 |
![]()
ABT
Abbott Laboratories
|
140.22 | 241.69B | 41.95B | 13.40B | 6.35B | 7.65 |
![]()
BSX
Boston Scientific Corp
|
104.90 | 153.75B | 16.75B | 1.85B | 2.37B | 1.25 |
![]()
SYK
Stryker Corp
|
394.88 | 150.24B | 22.60B | 2.99B | 3.49B | 7.76 |
![]()
MDT
Medtronic Plc
|
94.30 | 120.56B | 33.20B | 4.26B | 5.47B | 3.29 |
![]()
EW
Edwards Lifesciences Corp
|
71.42 | 42.42B | 5.72B | 4.17B | 490.10M | 6.97 |
Adapthealth Corp Stock (AHCO) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jan-08-24 | Downgrade | Jefferies | Buy → Hold |
Nov-08-23 | Downgrade | BofA Securities | Neutral → Underperform |
May-10-23 | Downgrade | Deutsche Bank | Buy → Hold |
May-10-23 | Downgrade | Stifel | Buy → Hold |
May-09-23 | Downgrade | BofA Securities | Buy → Neutral |
Sep-27-21 | Initiated | SVB Leerink | Outperform |
Jul-14-21 | Upgrade | Robert W. Baird | Neutral → Outperform |
Apr-13-21 | Downgrade | Robert W. Baird | Outperform → Neutral |
Mar-18-21 | Initiated | Truist | Buy |
Jan-26-21 | Initiated | BofA Securities | Buy |
Dec-10-20 | Initiated | UBS | Buy |
Aug-10-20 | Initiated | Canaccord Genuity | Buy |
Jul-01-20 | Resumed | SVB Leerink | Outperform |
Jun-09-20 | Initiated | RBC Capital Mkts | Outperform |
Jan-31-20 | Initiated | Stifel | Buy |
Jan-07-20 | Initiated | Jefferies | Buy |
Dec-11-19 | Initiated | SVB Leerink | Outperform |
Dec-10-19 | Initiated | Deutsche Bank | Buy |
View All
Adapthealth Corp Stock (AHCO) Latest News
Is AdaptHealth (AHCO) a Great Value Stock Right Now? - Yahoo Finance
AdaptHealth Corp. Reports Positive 2024 Results and Sets 2025 Growth Strategy - MSN
Results: AdaptHealth Corp. Beat Earnings Expectations And Analysts Now Have New Forecasts - Yahoo Finance UK
Decoding AdaptHealth Corp (AHCO): A Strategic SWOT Insight - GuruFocus.com
AHCO LOSS NOTICE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages AdaptHealth Corp. Investors with LARGE LOSSES to Secure Counsel Before Important DeadlineAHCO, AHCOW - ACCESS Newswire
AdaptHealth price target raised to $14 from $11 at RBC Capital - Yahoo Finance
UBS Adjusts AdaptHealth Price Target to $14 From $11, Maintains Buy Rating -February 27, 2025 at 08:39 am EST - Marketscreener.com
AdaptHealth Corp (AHCO) Q4 2024 Earnings Call Highlights: Revenu - GuruFocus.com
AdaptHealth CorpOrdinary SharesClass A to Host Earnings Call - ACCESS Newswire
4 Analysts Assess AdaptHealth: What You Need To Know - Benzinga
Is Aurora Cannabis (ACB) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Truist Securities Adjusts AdaptHealth Price Target to $14 From $12, Maintains Buy Rating - Marketscreener.com
AdaptHealth Corp. (NASDAQ:AHCO) Q4 2024 Earnings Call Transcript - Insider Monkey
RBC Raises Price Target on AdaptHealth to $14 From $11, Keeps Outperform Rating - Marketscreener.com
These 4 Measures Indicate That AdaptHealth (NASDAQ:AHCO) Is Using Debt Extensively - Simply Wall St
AdaptHealth Corp (AHCO) Q4 2024 Earnings Call Highlights: Revenue Growth and Strategic ... - Yahoo Finance
AdaptHealth Corp. Reports 2024 Financial Results and 2025 Outlook - TipRanks
Dow Surges 200 Points; Keurig Dr Pepper Posts Upbeat Earnings - Benzinga
AdaptHealth Corp. Sees 28% Surge in Shares Following Strong Q4 ResultsNews and Statistics - IndexBox, Inc.
Why AdaptHealth (AHCO) Stock Is Trading Up Today - MSN
Why AdaptHealth (AHCO) Stock Is Trading Up Today By Stock Story - Investing.com Canada
Itron Posts Upbeat Results, Joins AdaptHealth, EverQuote, Goosehead Insurance And Other Big Stocks Moving Higher On Tuesday - Benzinga
AdaptHealth (AHCO) Surges 27.71%: Is This a Buying Opportunity? - RagingBull
AdaptHealth Corp. Reports Strong Q4 Results: Surpasses Revenue ExpectationsNews and Statistics - IndexBox, Inc.
An known buyer entered into a definitive agreement to acquire Certain Incontinence Assets of Wellness at Home Segment. - Marketscreener.com
Adapthealth earnings beat by $0.06, revenue topped estimates - Investing.com
AdaptHealth Corp. (AHCO) Q4 Earnings and Revenues Surpass Estimates - Yahoo Finance
AdaptHealth (NASDAQ:AHCO) Posts Better-Than-Expected Sales In Q4, Stock Soars By Stock Story - Investing.com Canada
AdaptHealth Swings to Profit in Q4, Revenue Declines; Shares Gain Pre-Bell -February 25, 2025 at 08:19 am EST - Marketscreener.com
AdaptHealth reports Q4 earnings beat, issues 2025 guidance By Investing.com - Investing.com Canada
Earnings Flash (AHCO) ADAPTHEALTH CORP. Reports Q4 Revenue $856.6M, vs. FactSet Est of $829.2M - Marketscreener.com
(AHCO) AdaptHealth Expects Fiscal 2025 Net Revenue Range $3.22B$3.36B, vs. FactSet Est of $3.33B - Marketscreener.com
AdaptHealth (NASDAQ:AHCO) Posts Better-Than-Expected Sales In Q4, Stock Soars - Yahoo Finance
AdaptHealth reports Q4 earnings beat, issues 2025 guidance - Investing.com
AdaptHealth Corp. Announces Fourth Quarter and Full-Year 2024 Results - TradingView
Earnings Scheduled For February 25, 2025 - Benzinga
AdaptHealth Corp (AHCO) Q4 2024 Earnings Report Preview: What to Expect - Yahoo Finance
AdaptHealth Corp. Q4 2024 Earnings Preview - MSN
AdaptHealth (AHCO) Expected to Announce Earnings on Tuesday - Defense World
Levi & Korsinsky, LLP Notifies Shareholders of AdaptHealth Corp. (AHCO) an Upcoming Claims Deadline in a Class Action Settlement - ACCESS Newswire
AdaptHealth Corp to Host Earnings Call - ACCESS Newswire
Down -16.54% in 4 Weeks, Here's Why AdaptHealth (AHCO) Looks Ripe for a Turnaround - MSN
Stratos Wealth Partners LTD. Has $120,000 Position in AdaptHealth Corp. (NASDAQ:AHCO) - Defense World
UBS Group Has Lowered Expectations for AdaptHealth (NASDAQ:AHCO) Stock Price - Defense World
Empowered Funds LLC Grows Stock Position in AdaptHealth Corp. (NASDAQ:AHCO) - MarketBeat
Winners And Losers Of Q3: AdaptHealth (NASDAQ:AHCO) Vs The Rest Of The Senior Health, Home Health & Hospice Stocks - The Globe and Mail
AHCO or ABT: Which Is the Better Value Stock Right Now? - MSN
UBS Adjusts Price Target on AdaptHealth to $11 From $12, Keeps Buy Rating -February 13, 2025 at 09:39 am EST - Marketscreener.com
Should Value Investors Buy AdaptHealth (AHCO) Stock? - Nasdaq
10 Health Care Stocks With Whale Alerts In Today's Session - Benzinga
Daily Progress: AdaptHealth Corp (AHCO) Drop -3.42, Closing at 9.33 - The Dwinnex
Adapthealth Corp Stock (AHCO) Financials Data
Revenue
Net Income
Cash Flow
EPS
Adapthealth Corp Stock (AHCO) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
Clemens Jason A | Chief Financial Officer |
Dec 10 '24 |
Sale |
9.35 |
35,000 |
327,250 |
420,719 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):